TMR Research announces a new report on the global stem cell assay market. The report examines the historical growth trajectory exhibited by the global stem cell assay market and its latest figures, and further provides reliable forecasts for the stem cell assay market based on complete analysis of the markets database.
Biopharma companies that are focused on cell therapies have reported promising clinical trial results in their ability to treat acute respiratory distress syndrome (ARDS), a condition that has shown to be a significant contributor to higher mortality in COVID-19 cases. In an Alliance for Regenerative Medicine (ARM) webinar on the topic, Michael Lehmicke, director, science and industry affairs at ARM, noted that developers are utilizing mesenchymal stem cells (MSCs) and other stromal cells to treat ARDS caused by COVID-19. The number of clinical trials now underway continues to increase with many more at the preclinical stage
NEW YORK, July 27, 2020 /PRNewswire/ --BrainStorm-Cell Therapeutics Inc. (NASDAQ: BCLI), a leader in developing innovative autologous cellular therapies for highly debilitating neurodegenerative diseases, announced today that the Company will hold a conference call to update shareholders on financial results for the second quarter ended June 30, 2020, and provide a corporate update, at 8:00 a.m., Eastern Daylight Time (EDT), on Wednesday, August 5 2020.
QY Research has Published Latest Trending Report on Global Stem Cells Market Los Angeles, United State, The report titledGlobal Stem Cells Marketis one of the most comprehensive and important additions to QY Researchs archive of market research studies. It offers detailed research and analysis of key aspects of the global Stem Cells market. The market analysts authoring this report have provided in-depth information on leading growth drivers, restraints, challenges, trends, and opportunities to offer a complete analysis of the global Stem Cells market
The Stem Cell Therapy report provides independent information about the Stem Cell Therapy industry supported by extensive research on factors such as industry segments size & trends, inhibitors, dynamics, drivers, opportunities & challenges, environment & policy, cost overview, porters five force analysis, and key companies profiles including business overview and recent development.
Twenty years ago, scientists stunned the world when they announced they had decoded the genes that make up a human being. They hoped to use that genetic blueprint to advance something called gene therapy which locates and fixes the genes responsible for different diseases. As we first reported last year, a clinical trial at the National Institutes of Health is doing exactly that in an attempt to cure sickle cell anemia a devastating genetic disease that kills hundreds of thousands of people around the world every year
Human bodies do a lot of weird stuff. But goosebumps may be one of our strangest bodily functions. Goosebumps are humanitys near-universal reaction to the cold.
We all know what goosebumps are, but why have we evolved to hang on to this seemingly pointless physical reaction to the cold? New research suggests an answer: regulating stem cells that control hair follicles and hair growth. In a detailed analysis of mice, scientists found that the specific muscles that contract when goosebumps appear are connected to the sympathetic nervous system.
Today, Canadian Blood Servicesand Canadas COVID-19 Immunity Task Force (CITF)are releasing initial results of the first 10,000 blood donor samples assessed for SARS-CoV-2 antibodies. This analysis reveals that over the period May 9 through June 8, 2020, fewer than 1 per cent of the 10,000 samples from blood donors tested positive for antibodies to the novel coronavirus
Its Friday! Since most of our news consumption consists of bad news, especially during this time with a pandemic, rioting, protests, murder hornets, alcoholic killer monkeys, meth gators, and squirrels carrying the Bubonic Plague.
Recent Comments